Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R AntagonistFebruary 3, 2025
Dell ends hybrid work policy, becomes latest tech giant to force workers back to the office full-timeFebruary 3, 2025
GROCERY OUTLET INVESTOR NOTICE: Grocery Outlet Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 3, 2025
Share Twitter Facebook LinkedIn Email Bitcoin bottomed at $91.5k after growing global trade warn concerns ignited by President Trump’s tariffs.Read More
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R AntagonistFebruary 3, 2025
Trump plans to cut US funding to South Africa over land law. Musk has also criticized the countryFebruary 3, 2025
